v3.25.4
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Follow-on Public Offering
Common Stock
Common Stock
Follow-on Public Offering
Additional Paid-in Capital
Additional Paid-in Capital
Follow-on Public Offering
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022     21,702        
Beginning balance at Dec. 31, 2022 $ 708,480   $ 2   $ 716,343   $ (7,865)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 76,638       76,638    
Net loss (80,535)           (80,535)
Issuance of common stock in connection with At-The-Market offering net of underwriting discounts and commissions and other offering costs (in shares)     400        
Issuance of common stock in connection with At-The-Market offering net of underwriting discounts and commissions and other offering costs 44,815       44,815    
Issuance of shares upon vesting of restricted stock units, net of tax withholdings (in shares)     590        
Issuance of shares upon vesting of restricted stock units, net of tax withholdings (41,346)       (41,346)    
Ending balance (in shares) at Dec. 31, 2023     22,692        
Ending balance at Dec. 31, 2023 708,052   $ 2   796,450   (88,400)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 89,122       89,122    
Net loss (93,601)           (93,601)
Issuance of common stock in connection with At-The-Market offering net of underwriting discounts and commissions and other offering costs (in shares)     333        
Issuance of common stock in connection with At-The-Market offering net of underwriting discounts and commissions and other offering costs 48,779       48,779    
Issuance of shares upon vesting of restricted stock units, net of tax withholdings (in shares)     573        
Issuance of shares upon vesting of restricted stock units, net of tax withholdings $ (52,633)       (52,633)    
Ending balance (in shares) at Dec. 31, 2024 23,598   23,598        
Ending balance at Dec. 31, 2024 $ 699,719   $ 2   881,718   (182,001)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 102,353       102,353    
Net loss (42,903)           (42,903)
Issuance of common stock in connection with At-The-Market offering net of underwriting discounts and commissions and other offering costs (in shares)     263 2,013      
Issuance of common stock in connection with At-The-Market offering net of underwriting discounts and commissions and other offering costs 64,277 $ 387,338 $ 1   64,277 $ 387,337  
Issuance of shares upon vesting of restricted stock units, net of tax withholdings (in shares)     425        
Issuance of shares upon vesting of restricted stock units, net of tax withholdings $ (54,602)       (54,602)    
Ending balance (in shares) at Dec. 31, 2025 26,299   26,299        
Ending balance at Dec. 31, 2025 $ 1,156,182   $ 3   $ 1,381,083   $ (224,904)